Show simple item record

dc.contributor.authorLee, D
dc.contributor.authorEmblin, K
dc.contributor.authorDaniels, R
dc.contributor.authorKallis, TJ
dc.contributor.authorAlallan, M
dc.contributor.authorMokbel, K
dc.date.accessioned2024-11-08T11:05:20Z
dc.date.issued2025
dc.date.updated2024-11-08T10:37:14Z
dc.description.abstractBackground/Aim: Transient ischaemic attack (TIA) is characterised by a temporary neurological dysfunction resulting from focal ischaemia in the brain, spinal cord or retina without acute infarction. These episodes typically last less than 24 hours and are significant predictors of subsequent ischaemic strokes. Hypertension is a major risk factor for cerebrovascular events, and primary aldosteronism (PA) is recognised as a common cause of secondary hypertension. This case report presents a male patient with secondary hypertension due to Conn Syndrome, a form of PA, who experienced a TIA manifesting as left leg weakness, underscoring the heightened stroke risk associated with secondary hypertension. Case Report: A 78-year-old male with secondary hypertension caused by Conn Syndrome presented with an episode of left leg weakness that resolved within 24 hours. After ruling out other potential causes such as metabolic disturbances, infections, and structural brain lesions, he was diagnosed with TIA and treated with dual antiplatelet therapy. A carotid ultrasound revealed significant stenosis, leading to a referral for carotid endarterectomy. Long-term management included clopidogrel monotherapy and optimising hypertension control. Conclusion: This case highlights the increased stroke risk in patients with Conn Syndrome-related hypertension, emphasising the importance of early recognition and optimising hypertension management in patients with secondary hypertension to prevent future cerebrovascular events.en_GB
dc.description.sponsorshipUniversity of Exeteren_GB
dc.identifier.citationAwaiting citation and DOIen_GB
dc.identifier.urihttp://hdl.handle.net/10871/138053
dc.language.isoenen_GB
dc.publisherInternational Institute of Anticancer Researchen_GB
dc.rights.embargoreasonUnder temporary indefinite embargo pending publication by the International Institute of Anticancer Research. No embargo required on publication. AAM to be replaced with published version on publication en_GB
dc.rights©2025 The Author(s). Published by the International Institute of Anticancer Research. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).en_GB
dc.subjectTransient ischaemic attacken_GB
dc.subjectstrokeen_GB
dc.subjectcerebrovascular eventsen_GB
dc.subjectaldosteronismen_GB
dc.subjectConn Syndromeen_GB
dc.subjectsecondary hypertensionen_GB
dc.subjectdifferential diagnosisen_GB
dc.titleTransient ischaemic attack in a patient with Conn syndrome: A case report and literature review on the importance of identifying secondary hypertensionen_GB
dc.typeArticleen_GB
dc.date.available2024-11-08T11:05:20Z
dc.identifier.issn0258-851X
dc.descriptionThis is the author accepted manuscript. The final version is available from the International Institute of Anticancer Research via the DOI in this record en_GB
dc.descriptionData Availability: All data relevant to the study are included in the article.en_GB
dc.identifier.eissn1791-7549
dc.identifier.journalIn Vivoen_GB
dc.relation.ispartofIn Vivo
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/ en_GB
dcterms.dateAccepted2024-10-17
dcterms.dateSubmitted2024-10-11
rioxxterms.versionAMen_GB
rioxxterms.licenseref.startdate2024-10-17
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2024-11-08T10:37:16Z
refterms.versionFCDP
refterms.panelAen_GB
exeter.rights-retention-statementYes


Files in this item

This item appears in the following Collection(s)

Show simple item record

©2025 The Author(s). Published by the International Institute of Anticancer Research. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).
Except where otherwise noted, this item's licence is described as ©2025 The Author(s). Published by the International Institute of Anticancer Research. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).